Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Serologic Characterization of Bone-healing

This study has been withdrawn prior to enrollment.
(Lack of patients, lack of funding for analysis)
Sponsor:
Collaborator:
CCBR Clinical Research Center, Aalborg, Denmark
Information provided by:
Northern Orthopaedic Division, Denmark
ClinicalTrials.gov Identifier:
NCT00377884
First received: September 18, 2006
Last updated: April 2, 2014
Last verified: April 2014
  Purpose

Investigation of serologic bone markers in patients undergoing hip arthroplasty


Condition Phase
Arthritis
Phase 1

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Serologic Based Molecular Characterization of Bone-healing After Cementless Total Hip Arthroplasty

Further study details as provided by Northern Orthopaedic Division, Denmark:

Enrollment: 0
Study Start Date: January 2004
Estimated Study Completion Date: June 2009
Primary Completion Date: June 2009 (Final data collection date for primary outcome measure)
Detailed Description:

Investigation of serologic bone markers in patients undergoing hip arthroplasty. Measured by frequent blood- and urine samples pre-operative and during the first post-operative year.

  Eligibility

Ages Eligible for Study:   40 Years to 80 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

patients planned for cementless THR for OA in the hip

Criteria

Inclusion Criteria:

  • Ages 40-80 years
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00377884

Locations
Denmark
Northern Orthopaedic Division
Aalborg, Northern Jutland, Denmark
Aalborg University Hospital
Aalborg, Denmark, 9000
Sponsors and Collaborators
Northern Orthopaedic Division, Denmark
CCBR Clinical Research Center, Aalborg, Denmark
Investigators
Principal Investigator: Mogens B Laursen, MD, Phd Northern Orthopaedic Division
  More Information

No publications provided

Responsible Party: Northern Orthopaedic Division, Orthopaedic Research Unit, Aarhus University - Aalborg Hospital, Denmark
ClinicalTrials.gov Identifier: NCT00377884     History of Changes
Other Study ID Numbers: ON-04-018-MBL
Study First Received: September 18, 2006
Last Updated: April 2, 2014
Health Authority: Denmark: The Danish National Committee on Biomedical Research Ethics
Denmark: Danish Dataprotection Agency

Keywords provided by Northern Orthopaedic Division, Denmark:
THA

ClinicalTrials.gov processed this record on November 25, 2014